| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 59,165 | 53,814 | 49,941 | 52,404 | | Cost of Revenue | 37,480 | 35,631 | 33,950 | 52,752 | | | Gross Profit | 21,685 | 18,183 | 15,991 | (348) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,322 | 6,743 | 6,131 | (8,246) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| (3,530) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,363 | 11,440 | 9,860 | 11,428 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46 | 56 | 97 | 199 | | Earnings Before Interest And Taxes | 14,409 | 11,496 | 9,957 | 11,627 | | Interest Expense | 255 | 278 | 287 | 354 | | Income Before Tax | 14,154 | 11,218 | 9,670 | 11,273 | | Income Tax Expense | 5,774 | 4,580 | 3,965 | 4,215 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,380 | 6,638 | 5,705 | 7,058 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,380 | 6,638 | 5,705 | 7,058 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,380 | $6,638 | $5,705 | $7,058 |
|
0.28% Nasdaq 
Income Statement
